Obestatin (human) – 500 µg

Brand:
Cayman
CAS:
1081110-72-6
Storage:
-20
UN-No:
Non-Hazardous - /

Obestatin is a 23 amino acid peptide hormone with a conserved C-terminal glycine residue and amidation site that is formed by cleavage of the ghrelin and obestatin prepropeptide.{13636} It binds to the orphan receptor GPR39 (Kd = 1 nM) and stimulates cAMP production in CHO and HEK293 cells overexpressing human GPR39. Obestatin inhibits contraction of isolated mouse jejunum muscle strips induced by ghrelin (Item Nos. 15072 | 24458). In vivo, obestatin (12.5-1,000 nmol/kg) suppresses food intake in a time- and dose-dependent manner and reduces body weight gain and gastric emptying in mice. Obestatin (0.22 g per animal) also reduces food intake and glucose response without affecting plasma insulin responses in fasted high-fat diet fed mice.{38829}  

 

Available on backorder

SKU: 24552 - 500 µg Category:

Description

A peptide hormone; binds to the orphan receptor GPR39 (Kd = 1 nM) and stimulates cAMP production in CHO and HEK293 cells overexpressing human GPR39; suppresses food intake in a time- and dose-dependent manner and reduces body weight gain and gastric emptying in mice (12.5-1,000 nmol/kg); reduces food intake and glucose response without affecting plasma insulin responses in fasted high-fat diet fed mice (0.22 g per animal) ,


Formal name: L-phenylalanyl-L-asparaginyl-L-alanyl-L-prolyl-L-phenylalanyl-L-α-aspartyl-L-valylglycyl-L-isoleucyl-L-lysyl-L-leucyl-L-serylglycyl-L-valyl-L-glutaminyl-L-tyrosyl-L-glutaminyl-L-glutaminyl-L-histidyl-L-seryl-L-glutaminyl-L-alanyl-L-leucinamide

Synonyms: 

Molecular weight: 2,546.80

CAS: 1081110-72-6

Purity: ≥95%

Formulation: A lyophilized powder


Product Type|Biochemicals|Peptides|Peptide Hormones||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Cofactors & Vitamins||Research Area|Endocrinology & Metabolism|Hormones & Receptors||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity